MSG
ARKG icon

Main Street Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Main Street Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252 Sell
6
-100
-94% -$3.19K ﹤0.01% 800
2026
Q1 		$2.8K Buy
+106
New +$3.1K ﹤0.01% 710
2025
Q4 		– Sell
-6
Closed -$167 – 121
2025
Q3 		$167 Hold
6
– – ﹤0.01% 774
2025
Q2 		$146 Hold
6
– – ﹤0.01% 754
2025
Q1 		$125 Hold
6
– – ﹤0.01% 765
2024
Q4 		$142 Hold
6
– – ﹤0.01% 742
2024
Q3 		$154 Hold
6
– – ﹤0.01% 747
2024
Q2 		$139 Hold
6
– – ﹤0.01% 844
2024
Q1 		$170 Hold
6
– – ﹤0.01% 878
2023
Q4 		$196 Buy
+6
New +$163 ﹤0.01% 1242

Other funds holding ARKG

MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM
CFIM
Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PWM
Purus Wealth Management Newport Beach, California $363M AUM 39.16% 1-Year Est. Return
LW
Lauer Wealth Valparaiso, Indiana $167M AUM 23.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Main Street Group's ARKG Position: Q2 2026 in Review

Main Street Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 94% in Q2 2026, selling an estimated $3.19K and leaving 6 shares worth $252. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Main Street Group first reported a position in ARKG in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.8K in Q1 2026. 41 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Main Street Group held 6 shares of ARK Genomic Revolution ETF worth $252 as of Q2 2026.
  • Main Street Group sold 100 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $3.19K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #800 holding.
  • Main Street Group first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's ARK Genomic Revolution ETF position peaked at $2.8K in Q1 2026.
  • 41 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.